History


Envaste Ltd. was founded in 2009 in Galway (Ireland) pioneering the manufacture of stretch-blow molded medical balloons used for cardiac and other novel minimally invasive procedures. Thanks to a knowledgeable and perseverant team, the company’s innovative balloon expertise soon became recognized as the “gold standard” for high performance medical catheters, prompting a new range of instruments.

In early 2012, a strategic decision was made to accelerate the growth of the company and a joint-venture was made which resulted in setting up of Envaste Ltd. (Mauritius).

Envaste Ltd. (Mauritius) was established as a domestic company incorporated in the Republic of Mauritius, an island situated in the southern hemisphere of the Indian Ocean. Its objectives are to design, manufacture and market medical instruments for the international market. Critical factors such as immediate customer and business impact, local workforce skills, political and economical stability, modern infrastructure, protection of intellectual property rights and finally a position between America, Europe and Asia for worldwide deliveries, made Mauritius the best location for business.

Sustaining and fueling our growth was pivotal for our success so that we could keep up investing heavily into R&D and continue developing new products. Benefiting from the highest standards of catheter technologies was a vital asset for success. Since 2009, we have grown our technical and product capability with products approved throughout the world. With these resources, Envaste is uniquely positioned to offer a total solutions approach encompassing product design and development, in-house balloon forming, top assembly, packaging, sterilization and regulatory capabilities.

Today, Envaste is dedicated to continue its innovative product line which offers substantial benefits to patients, physicians and health care systems. The company now possesses two business units platforms for treating patients with urology and gastroenterology diseases around the world.